Laboratory observation on low molecular heparin for treating high coagulation state in patients with nephrotic syndrome
10.3969/j.issn.1671-8348.2015.14.017
- VernacularTitle:低分子肝素治疗肾病综合征患者高凝状态的实验室观察
- Author:
Gang DAN
;
Yuan LIU
;
Zhongyong JIANG
;
Lina HU
;
Jing JIN
;
Xue GENG
;
Lijuan WU
- Publication Type:Journal Article
- Keywords:
low molecular heparin;
nephrotic syndrome;
hypercoagulability
- From:
Chongqing Medicine
2015;(14):1916-1917
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the curative effect of low molecular heparin for treating secondary high coagulation state in the patients with nephrotic syndrome(NS) .Methods Total 87 cases of NS in our hospital were divided into the conventional treat‐ment group (n=42) and the low molecular heparin treatment group (n=45) .The routine treatment group was given the prednisone treatment and the low molecular heparin treatment group was treated by low molecular heparin combined with prednisone .The re‐lated indicators of blood coagulation before and after treatment were detected and the clinical curative effects in two groups were an‐alyzed .Results The coagulation related indicators in the conventional treatment group had no statistically significant difference be‐tween before and after treatment (P>0 .05) ,the prothrombin time(PT) and activated partial thrombin time(APTT) after treat‐ment in the low molecular heparin treatment group were significantly extended compared with before treatment ,while the concen‐trations of D‐dimer and fibrinogen were significantly decreased and the concentration of antithrombin Ⅲ was markedly increased compared with before treatment ,showing statistically significant differences between the two groups (P<0 .05);the patients of the low molecular heparin group patients had no bleeding after treatment .Conclusion Low molecular heparin combined with predni‐sone can reduce the secondary high condensation state in NS without bleeding and has a significantly clinical effect .
